54
Views
2
CrossRef citations to date
0
Altmetric
Papers Presented at the 2nd Workshop on Radiation and Multidrug Resistance Mediated via the Tumour-Microenvironment

p53 and γ radiation in the normal breast

, , &
Pages 1026-1031 | Received 05 May 2009, Accepted 13 Aug 2009, Published online: 06 Nov 2009
 

Abstract

Purpose: With the increasing use of radiation as adjuvant therapy in breast cancer, the effects of γ radiation on the remaining normal breast are of increasing importance. The complexities of multiple cellular types within breast tissues and the role of the pleiotropic Tumour Protein 53 (TP53, p53) protein with its downstream transcriptional targets and cellular processes may be central to the effects on residual normal breast tissues.

Conclusion: While a detailed understanding of p53 protein-mediated responses in normal breast tissues remains elusive, p53 appears to have a pivotal role in the effects of γ radiation on normal breast epithelium, but not stromal cells, which may account for the differing clinical effects of γ radiation in women treated for breast cancer.

Acknowledgments

The authors thank Karen Murray for technical expertise. This work is supported by Breast Cancer Research Scotland.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.